Hims & Hers Health, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims & Hers Health, Inc., (“Hims" or the "Company") (NYSE:HIMS) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or join the case via https://portnoylaw.com/hims-hers-health-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

The New York Times reported on February 7, 2026, that the Company intended to cease sales of its own version of Wegovy, the popular weight loss medication manufactured by competitor Novo Nordisk. In the report, a former FDA commissioner noted that the technology used by Hims differed from that of Novo Nordisk. He further stated that he was “not aware of any clinical trial data that suggests that the product that they wanted to sell actually worked using the technology that they used,” raising questions about the efficacy of the specific technology employed for their version of the drug.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
[email protected]
310-692-8883
www.portnoylaw.com

Attorney Advertising

You May Also Be Interested In

• B.C. households cutting back on groceries and essentials as cost-of-living crisis worsens: new survey
• Artificial Intelligence Solutions Built by People with Capital Deployment, Global Risk & Corporate Strategy Experience
• Season 2 of Canadian Screen Award nominee The Squeaky Wheel: Canada debuts July 6 on AMI-tv and AMI+